504 related articles for article (PubMed ID: 24503766)
1. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha A; Remark R; Del Valle DM; Chuang LS; Chai Z; Alves I; Azevedo C; Gaifem J; Martin J; Petralia F; Tuballes K; Barcessat V; Tai SL; Huang HH; Laface I; Jerez YA; Boschetti G; Villaverde N; Wang MD; Korie UM; Murray J; Choung RS; Sato T; Laird RM; Plevy S; Rahman A; Torres J; Porter C; Riddle MS; Kenigsberg E; Pinho SS; Cho JH; Merad M; Colombel JF; Gnjatic S
Gastroenterology; 2022 Sep; 163(3):659-670. PubMed ID: 35623454
[TBL] [Abstract][Full Text] [Related]
3. Regulation of myeloid development and function by colony stimulating factors.
Barreda DR; Hanington PC; Belosevic M
Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
[TBL] [Abstract][Full Text] [Related]
4. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
Xu Y; Hunt NH; Bao S
Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease: innate immunodeficiency?
Yamamoto-Furusho JK; Korzenik JR
World J Gastroenterol; 2006 Nov; 12(42):6751-5. PubMed ID: 17106921
[TBL] [Abstract][Full Text] [Related]
7. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF treatment for Crohn's disease: a stimulating new therapy?
Wilk JN; Viney JL
Curr Opin Investig Drugs; 2002 Sep; 3(9):1291-6. PubMed ID: 12498002
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39
Weinhage T; Däbritz J; Brockhausen A; Wirth T; Brückner M; Belz M; Foell D; Varga G
Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):433-449.e1. PubMed ID: 28210690
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
Nylund CM; D'Mello S; Kim MO; Bonkowski E; Däbritz J; Foell D; Meddings J; Trapnell BC; Denson LA
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):542-8. PubMed ID: 21502824
[TBL] [Abstract][Full Text] [Related]
11. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
[TBL] [Abstract][Full Text] [Related]
12. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing.
Bernasconi E; Favre L; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Croze E; Velichko S; Parkinson J; Michetti P; Velin D
Inflamm Bowel Dis; 2010 Mar; 16(3):428-41. PubMed ID: 19639560
[TBL] [Abstract][Full Text] [Related]
14. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
15. The role of granulocyte macrophage-colony stimulating factor in gastrointestinal immunity to salmonellosis.
Coon C; Beagley KW; Bao S
Scand J Immunol; 2009 Aug; 70(2):106-15. PubMed ID: 19630916
[TBL] [Abstract][Full Text] [Related]
16. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation.
Däbritz J; Weinhage T; Varga G; Wirth T; Walscheid K; Brockhausen A; Schwarzmaier D; Brückner M; Ross M; Bettenworth D; Roth J; Ehrchen JM; Foell D
J Immunol; 2015 Mar; 194(5):2424-38. PubMed ID: 25653427
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
19. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
Vremec D; Lieschke GJ; Dunn AR; Robb L; Metcalf D; Shortman K
Eur J Immunol; 1997 Jan; 27(1):40-4. PubMed ID: 9021996
[TBL] [Abstract][Full Text] [Related]
20. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
